Products for Research Use Only
RegisterLogin

PF-06745013

CAT: 0804-HY-123965Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-123965Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PF-06745013 (Compound 37) is a MAP4K4 inhibitor without time-dependent inhibition (TDI) risk of CYP3A4 (IC50 of 0.4 nM for MAP4K4) . PF-06745013 has no accumulation CNS-impaired and non-ATP competitive activities in mouse models. PF-06745013 can be used for inflammatory diseases like diabetes and cancers research[1].
CAS Number
2089334-01-8
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
MAP4K; TNF Receptor
Related Pathways
Apoptosis; MAPK/ERK Pathway
Field of Research
Cancer; Metabolic Disease
Smiles
O=C(C(C)(C)OC1=CC=C(C2=CN=C(C(C3=CC=C(Cl)C=C3)=C2)N)C=C1)O
Molecular Formula
C21H19ClN2O3
Molecular Weight
382.84
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362-P403+P233-P405-P501
References & Citations
[1]Dow RL, et al. 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety. J Med Chem. 2018 Apr 12;61 (7) :3114-3125.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MAP4K4/HGK

Related Products

CatalogName
HY-P990649-01PF-5212374
HY-111965-01PF-06647263
HY-10459-01PF-562271
HY-108341-01PF-06424439
HY-100398-01PF-04979064
HY-131972-01PF-06843195
HY-14464-01PF-00489791
HY-121163-01PF-184563
HY-124947PF-4522654
HY-116524PF-04781340

Alternative Products

CatalogName
T28375-01PF-06745013
MBS579460PF-03084014 (PF-3084014)
BA7029-25PF-04745637
A4374-5.1PF-3845
A8499-50PF-04691502
B8018-100PF 1022A
BA4631-10PF-739
A8320-SPF-00562271
BA6663-5.1PF-06372865
BA6335-10PF-06459988

Popular Products